Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Cardiac characteristics and natural progression in Taiwanese patients with mucopolysaccharidosis III.

Lin HY, Chen MR, Lin SM, Hung CL, Niu DM, Chang TM, Chuang CK, Lin SP.

Orphanet J Rare Dis. 2019 Jun 13;14(1):140. doi: 10.1186/s13023-019-1112-7.

2.

Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with Mucopolysaccharidosis IVA.

Lin HY, Chen MR, Lin SM, Hung CL, Niu DM, Chuang CK, Lin SP.

Orphanet J Rare Dis. 2018 Aug 29;13(1):148. doi: 10.1186/s13023-018-0883-6.

3.

Natural history of echocardiographic abnormalities in mucopolysaccharidosis III.

Wilhelm CM, Truxal KV, McBride KL, Kovalchin JP, Flanigan KM.

Mol Genet Metab. 2018 Jun;124(2):131-134. doi: 10.1016/j.ymgme.2018.04.010. Epub 2018 Apr 27.

PMID:
29735373
4.

Cardiovascular abnormalities in Taiwanese patients with mucopolysaccharidosis.

Lin SM, Lin HY, Chuang CK, Lin SP, Chen MR.

Mol Genet Metab. 2014 Apr;111(4):493-8. doi: 10.1016/j.ymgme.2014.02.009. Epub 2014 Feb 21.

PMID:
24598247
5.

Cardiac Ultrasound Findings in Infants with Severe (Hurler Phenotype) Untreated Mucopolysaccharidosis (MPS) Type I.

Schroeder L, Orchard P, Whitley CB, Berry JM, Tolar J, Miller W, Braunlin EA.

JIMD Rep. 2013;10:87-94. doi: 10.1007/8904_2012_208. Epub 2013 Feb 12.

6.

Cardiac abnormalities in adults with the attenuated form of mucopolysaccharidosis type I.

Soliman OI, Timmermans RG, Nemes A, Vletter WB, Wilson JH, ten Cate FJ, Geleijnse ML.

J Inherit Metab Dis. 2007 Oct;30(5):750-7. Epub 2007 Jun 14.

7.

Cardiac manifestations of the mucopolysaccharidoses.

Schieken RM, Kerber RE, Ionasescu VV, Zellweger H.

Circulation. 1975 Oct;52(4):700-5.

PMID:
808361
8.

Mucopolysaccharidosis VI: cardiac involvement and the impact of enzyme replacement therapy.

Kampmann C, Lampe C, Whybra-Trümpler C, Wiethoff CM, Mengel E, Arash L, Beck M, Miebach E.

J Inherit Metab Dis. 2014 Mar;37(2):269-76. doi: 10.1007/s10545-013-9649-4. Epub 2013 Sep 24.

PMID:
24062198
9.

Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study.

Wethal T, Lund MB, Edvardsen T, Fosså SD, Pripp AH, Holte H, Kjekshus J, Fosså A.

Br J Cancer. 2009 Aug 18;101(4):575-81. doi: 10.1038/sj.bjc.6605191. Epub 2009 Jul 21.

10.

The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure.

Schiattarella GG, Cerulo G, De Pasquale V, Cocchiaro P, Paciello O, Avallone L, Belfiore MP, Iacobellis F, Di Napoli D, Magliulo F, Perrino C, Trimarco B, Esposito G, Di Natale P, Pavone LM.

PLoS One. 2015 Jul 6;10(7):e0131662. doi: 10.1371/journal.pone.0131662. eCollection 2015.

11.

Cardiac structure and function and effects of enzyme replacement therapy in patients with mucopolysaccharidoses I, II, IVA and VI.

Lin HY, Chuang CK, Chen MR, Lin SM, Hung CL, Chang CY, Chiu PC, Tsai WH, Niu DM, Tsai FJ, Lin SJ, Hwu WL, Lin JL, Lin SP.

Mol Genet Metab. 2016 Apr;117(4):431-7. doi: 10.1016/j.ymgme.2016.02.003. Epub 2016 Feb 16.

PMID:
26899310
12.

Late diagnosis of mucopolysaccharidosis type IVB and successful aortic valve replacement in a 60-year-old female patient.

Dostalova G, Hlubocka Z, Lindner J, Hulkova H, Poupetova H, Vlaskova H, Sikora J, Linhart A, Zeman J, Magner M.

Cardiovasc Pathol. 2018 Jul - Aug;35:52-56. doi: 10.1016/j.carpath.2018.04.001. Epub 2018 Apr 12.

PMID:
29800929
13.

Long-term galsulfase enzyme replacement therapy in Taiwanese mucopolysaccharidosis VI patients: A case series.

Lin HY, Chuang CK, Wang CH, Chien YH, Wang YM, Tsai FJ, Chou YY, Lin SJ, Pan HP, Niu DM, Hwu WL, Ke YY, Lin SP.

Mol Genet Metab Rep. 2016 Apr 18;7:63-9. doi: 10.1016/j.ymgmr.2016.04.003. eCollection 2016 Jun.

14.

Aortic Valve Replacement.

Rajput FA, Zeltser R.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Mar 31.

15.

Cardiovascular changes in children with mucopolysaccharide disorders.

Mohan UR, Hay AA, Cleary MA, Wraith JE, Patel RG.

Acta Paediatr. 2002;91(7):799-804.

PMID:
12200906
16.

[Diagnostic value of mitral and septal echocardiographic changes in aortic valve insufficiency].

Daniel W, Walpurger G, Lichtlen P.

Z Kardiol. 1976 Jul;65(7):590-605. German.

PMID:
960975
17.

[The best of valvular heart disease in 2006].

de Gevigney G; Groupe de travail sur les valvulopathies de la Societe francaise de cardiologi.

Arch Mal Coeur Vaiss. 2007 Jan;100 Spec No 1:19-28. Review. French.

PMID:
17405561
18.
19.

[Cardiac manifestation of the mucopolysaccharidoses: periodical echocardiographic evaluation in six cases].

Tada A, Tanaka A, Yasuda M, Komatsu Y, Inoue E, Minamikawa H, Kozumi K, Yoshimura T, Ikuno Y, Oku H, et al.

J Cardiogr. 1983 Jun;13(2):407-23. Japanese.

PMID:
6427363
20.

Value of echocardiography and nuclear techniques in assessment of valvular heart lesions.

Iskandrian AS, Hakki AH, Kotler MN.

Cardiovasc Clin. 1986;17(1):181-200.

PMID:
2945637

Supplemental Content

Support Center